疾病状态下个体频率签名的漂移规律

Written by

in

Language

Evidence level: A

个体频率签名不是永动机——疾病会让它漂移:血管变硬、脑电变慢、自主调节衰减;漂移既是生物识别的安全漏洞,也是”脉证合参”式健康预警的科学内核。

正文

前几篇我们论证了个体频率签名的”稳定”:心电波形可认人、脉搏谐波 ICC 大于 0.9、脑电 α 峰频率高遗传高稳定。但稳定不等于恒定。当疾病来临时,这张”生理身份卡”会漂移——而且漂移有方向、有幅度、部分可逆。这正是中医”以脉测病”最值得现代科学检验的地方。

血管签名:生病就”变硬”

脉搏波速度(PWV)是血管签名里最成熟的指标——动脉越硬,脉搏波传得越快。Vlachopoulos 团队对 17 项纵向研究、15,877 人做了荟萃分析,随访平均 7.7 年:主动脉 PWV 最高三分位人群,未来心血管事件风险是最低三分位的 2.26 倍(95% CI 1.89-2.70),心血管死亡 2.02 倍,全因死亡 1.90 倍;PWV 每升高 1 m/s,事件风险增加 14-15%(PMID 20338492)。换句话说,血管签名每漂移一个单位,风险就上一个台阶——这就是”脉象变化预示病进”的定量版本。

更精细的是波形形状本身。基于储库波理论的脉搏波分析(PWA)提取的收缩/舒张速率常数(SC/DC),在两个独立前瞻队列(1,272 人随访 19.8 年 + 2,221 人随访 10 年)中稳定预测心血管死亡,风险比均约 1.18,且在校正传统风险因素后依然显著(PMID 27128568)。波形不是装饰,波形就是健康的编码。

神经签名:生病就”变慢”

大脑的频率签名同样会漂移,方向是”减慢”。一项 MEG 研究对比 27 名轻度认知障碍(MCI)患者与 24 名健康对照:α 峰频率在后部脑区显著降低——对照组平均 9.68 Hz,MCI 组 9.05 Hz,且峰频率与海马体积正相关(PMID 24409145)。海马是阿尔茨海默病最早受损的结构之一——频率变慢与结构损伤同步发生。

减慢还能预报病程。米兰圣拉斐尔医院 375 名记忆门诊患者的回顾性研究显示:脑电个体α频(IAF)在淀粉样蛋白阴性者中更高;在 Aβ 阳性的 MCI 患者里,IAF 显著更低者 2 年内转化为阿尔茨海默病的风险更高,且能预测转化时间(p<0.001, R=0.38)(PMID 39087560)。”大脑时钟”的走慢速度,成了病程进展的预报器。不过要泼一盆冷水:2024 年 NIA-AA 与欧洲神经科学学会指南并未把静息态脑电常规纳入痴呆临床工作流,尽管大量研究一致显示 δ/θ/α 节律异常与 AD 病理生物标志物相关(PMID 39978053)——证据充分,但离”处方级”应用还有距离。

自主神经签名:衰减即预后

心率的频率域参数(HRV 的 LF/HF/总功率)衡量自主神经的调节能力,疾病状态下它们系统性衰减,而衰减本身携带预后信息。一项 240 名糖尿病患者的 24 小时 HRV 研究随访 15.5 年,期间 49% 死亡:时域指标几乎全军覆没,但频域参数全部显著预测死亡,其中 LF 功率是独立预测因子,且基线 LF 在 5 年后依然有效(PMID 20844904)。另一项 655 名 2 型糖尿病患者的 7.8 年随访证实:合并心血管自主神经病变者 HRV 全面下降,最低十分位人群的总功率(HR 2.81)、LF(HR 2.68)、HF(HR 2.24)显著预测心血管事件(PMID 30006307)。频率参数不是”测着玩”的——低下去,就是要出事。

漂移可逆:病去则签回

最关键的一点:漂移不是单行道。上海瑞金医院团队的综述总结了 27 项安慰剂对照试验:降压药物普遍能降低 PWV,ACEI/ARB 类效果最明显,且改善独立于血压下降本身(PMID 26587429)。血管签名”硬”了能再”软”回来,脑电变慢能否拉回、HRV 衰减能否逆转,正是当下干预研究的主战场。这给中医”治未病”与”病进病退”提供了可测的标尺:治疗有效 = 频率签名向基线回归。

证据与局限

已验证: PWV 升高预测心血管事件与全因死亡(17 项纵向研究 meta,RR 1.90-2.26);MCI/AD 中 α 峰频率显著减慢且与海马体积相关;糖尿病 HRV 频域参数衰减预测远期死亡(15.5 年随访);降压治疗可降低 PWV(27 项安慰剂对照试验综述)。

部分验证: IAF 减慢预测 MCI 转 AD 仅单中心回顾性数据(375 人);PWA 储库参数预测死亡已双队列复制但机制未完全厘清;指南尚未将静息态脑电纳入常规痴呆诊断流程。

待验证: 多模态频率签名(脉搏+ECG+IAF)在千人级疾病队列中的漂移方向一致性;漂移-恢复的动力学曲线(病进多快、病退多慢);中医”脉证合参”对漂移的判读与现代频域指标的盲法对照。

相关阅读

证据等级: A
参考文献: PMID 20338492, PMID 27128568, PMID 24409145, PMID 39087560, PMID 39978053, PMID 20844904, PMID 30006307, PMID 26587429


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Drift Patterns of Individual Frequency Signatures Under Disease Conditions

Evidence level: A

An individual frequency signature is not a perpetual motion machine—illness causes it to drift: vessels stiffen, brainwave rates slow, and autonomic regulation attenuates. This drift represents both a security vulnerability in biometric identification and the scientific core of health warning systems akin to “pulse-symptom integration” in Traditional Chinese Medicine.

Main Text

In previous articles, we argued for the “stability” of individual frequency signatures: ECG waveforms can identify individuals, pulse harmonic ICC exceeds 0.9, and alpha peak frequencies in EEG show high heritability and stability. However, stability does not equal constancy. When illness arises, this “physiological ID card” drifts—and the drift is directional, has magnitude, and is partially reversible. This is precisely where Traditional Chinese Medicine’s “diagnosis via pulse assessment” offers the most compelling target for modern scientific validation.

Vascular Signature: Stiffening Upon Illness

Pulse Wave Velocity (PWV) is the most mature metric within the vascular signature—arteries become stiffer, and pulse waves transmit faster. A meta-analysis by the Vlachopoulos team across 17 longitudinal studies involving 15,877 individuals, with a mean follow-up of 7.7 years, found that the highest third of the population by aortic PWV faced a 2.26 times higher risk of future cardiovascular events compared to the lowest third (95% CI 1.89-2.70), a 2.02 times higher risk of cardiovascular death, and a 1.90 times higher risk of all-cause mortality; for every 1 m/s increase in PWV, event risk rises by 14-15% (PMID 20338492). In other words, each unit of drift in the vascular signature elevates risk to the next tier—this is the quantitative version of “pulse changes predicting disease progression.”

More refined analysis focuses on waveform morphology itself. Pulse Wave Analysis (PWA) based on reservoir wave theory extracts systolic/diastolic rate constants (SC/DC), which stably predict cardiovascular death in two independent prospective cohorts (1,272 individuals followed for 19.8 years + 2,221 individuals followed for 10 years), with hazard ratios averaging approximately 1.18, remaining significant even after adjusting for traditional risk factors (PMID 27128568). The waveform is not merely decorative; the waveform itself encodes health status.

Neural Signature: Slowing Upon Illness

The brain’s frequency signature also drifts, in the direction of “slowing.” A MEG study comparing 27 patients with Mild Cognitive Impairment (MCI) against 24 healthy controls found a significant reduction in alpha peak frequency in posterior brain regions—average 9.68 Hz in controls versus 9.05 Hz in the MCI group, with peak frequency positively correlated with hippocampal volume (PMID 24409145). The hippocampus is one of the earliest structures affected in Alzheimer’s disease—frequency slowing occurs synchronously with structural damage.

Slowing can also forecast disease progression. A retrospective study of 375 memory clinic patients at the Hospital of St. Raphael in Milan showed that individual alpha frequency (IAF) was higher in amyloid-negative individuals; among MCI patients with positive Aβ, those with significantly lower IAF had a higher risk of converting to Alzheimer’s disease within 2 years, and could predict the time to conversion (p<0.001, R=0.38) (PMID 39087560). The slowing speed of the brain’s “clock” has become a predictor of disease progression. However, a caveat must be noted: the 2024 NIA-AA and European Federation of Neurological Societies guidelines have not yet incorporated resting-state EEG into routine clinical workflows for dementia, despite extensive research consistently showing that δ/θ/α rhythm abnormalities correlate with AD pathological biomarkers (PMID 39978053)—evidence is robust, yet it remains distant from “prescription-level” application.

Autonomic Signature: Attenuation as Prognosis

Frequency domain parameters of heart rate (HRV LF/HF/Total Power) measure autonomic regulatory capacity. Under disease states, these parameters systematically attenuate, and the attenuation itself carries prognostic information. A 24-hour HRV study in 240 diabetic patients followed for 15.5 years, during which 49% died, found that time-domain metrics were almost entirely non-predictive, yet all frequency domain parameters significantly predicted mortality, with LF power serving as an independent predictor; baseline LF remained effective even 5 years later (PMID 20844904). Another study following 655 Type 2 diabetic patients for 7.8 years confirmed that those with concurrent cardiovascular autonomic neuropathy showed comprehensive HRV decline, where the lowest decile populations had significantly higher hazards for cardiovascular events: Total Power (HR 2.81), LF (HR 2.68), and HF (HR 2.24) (PMID 30006307). Frequency parameters are not for mere play—when they drop, adverse events follow.

Reversibility of Drift: Signature Returns with Recovery

The most critical point: drift is not a one-way street. A review by the team at Shanghai Ruijin Hospital summarized 27 placebo-controlled trials: antihypertensive medications generally reduce PWV, with ACEI/ARB classes showing the most pronounced effects, and improvements independent of blood pressure reduction itself (PMID 26587429). The vascular signature can “soften” again after becoming “hard”; whether slowed brainwaves can be restored and HRV attenuation reversed remains the current battleground for intervention research. This provides a measurable scale for TCM’s “treating before disease occurs” and concepts of “advancing and retreating disease”: effective treatment = frequency signature regression toward baseline.

Evidence and Limitations

Verified: Elevated PWV predicts cardiovascular events and all-cause mortality (meta-analysis of 17 longitudinal studies, RR 1.90-2.26); alpha peak frequency significantly slows in MCI/AD and correlates with hippocampal volume; diabetic HRV frequency parameters attenuate predicting long-term mortality (15.5-year follow-up); antihypertensive treatment reduces PWV (review of 27 placebo-controlled trials).

Partially Verified: IAF slowing predicting MCI-to-AD conversion relies on single-center retrospective data (375 individuals); PWA reservoir parameters predicting death replicated across two cohorts but mechanisms not fully elucidated; guidelines have not yet incorporated resting-state EEG into routine dementia diagnostic workflows.

Pending Verification: Consistency of drift direction across multimodal frequency signatures (pulse + ECG + IAF) in large-scale disease cohorts (>1,000 individuals); dynamic curves of drift-recovery (speed of progression vs. speed of recovery); blind comparative studies of TCM’s “pulse-symptom integration” interpretation against modern frequency domain metrics.

Related Reading

Evidence Level: A
References: PMID 20338492, PMID 27128568, PMID 24409145, PMID 39087560, PMID 39978053, PMID 20844904, PMID 30006307, PMID 26587429


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *